bioRxivCancer Biology
Systematic Discovery of the Functional Impact of Somatic Genome Alterations in Individual Tumors through Tumor-specific Causal Inference
C. Cai, G. Cooper, K. Lu, X. Ma, S. Xu, Z. Zhao, X. Chen, Y. Xue, A. Lee, N. Clark, V. Chen, S. Lu, L. Chen, L. Yu, H. Hochheiser, X. Jiang, J. Wang, X. Lu
Abstract
We report a tumor-specific causal inference (TCI) framework, which discovers causative somatic genome alterations (SGAs) through inferring causal relationships between SGAs and molecular phenotypes (e.g., transcriptomic, proteomic, or metabolomic changes) within an individual tumor. We applied the TCI algorithm to tumors from The Cancer Genome Atlas (TCGA) and identified those SGAs that causally regulate the differentially expressed genes (DEGs) within each tumor. Overall, TCI identified 634 SGAs that cause cancer-related DEGs in a significant number of tumors, including most of the previously known drivers and many novel candidate cancer drivers. The inferred causal relationships are statistically robust and biologically sensible, and multiple lines of experimental evidence support the predicted functional impact of both well-known and novel candidate drivers. By identifying major candidate drivers and revealing their functional impact in a tumor, TCI shed light on disease mechanisms of each tumor, providing useful information for advancing cancer biology and precision oncology.\n\nSignificance statementsCancer is mainly caused by SGAs. Precision oncology involves identifying and targeting tumor-specific aberrations resulting from causative SGAs. TCI is a novel computational framework for discovering the causative SGAs and their impact on oncogenic processes, thus revealing tumor-specific disease mechanisms. This information can be used to guide precision oncology.
- organism: human
- assay: whole-exome sequencing
- assay: proteomics
- assay: metabolomics
- assay: bulk RNA-seq
- research focus: variant effect prediction
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- research focus: benchmarking
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tumor-specific Causal Inference (TCI): A Bayesian Method for Identifying Causative Genome Alterations within Individual Tumors
Gregory F. Cooper, Chunhui Cai, Xinghua Lu·bioRxiv·Feb 28, 2018
- Comprehensive patient-level classification and quantification of driver events in TCGA PanCanAtlas cohorts
A. D. Vyatkin, D. V. Otnyukov, … A. V. Belikov·bioRxiv·Mar 17, 2021
- Unveiling Candidate Drivers in Cancer Progression Using Somatic-IV Analysis
Wei Zhang, Saba Ghaffari, … Kai Wang·bioRxiv·Feb 20, 2025
- Integrating gene mutation spectra from tumors and the general population with gene expression topological networks to identify novel cancer driver genes
Dan He, Ling Li, … Huiying Zhao·bioRxiv·May 2, 2023
- Identifying cancer pathway dysregulations using differential causal effects
Kim Philipp Jablonski, Martin Pirkl, … Niko Beerenwinkel·BioinformaticsPeer-reviewed·Dec 14, 2021
- DGAT-onco: A powerful method to detect oncogenes by integrating differential mutational analysis and functional impacts of somatic mutations
Haoyang Zhang, Junkang Wei, … Yuedong Yang·IEEE International Conference on Bioinformatics and Biomedicine (BIBM)Peer-reviewed·Dec 9, 2021